We are delighted to share with you Issue 27 of Maven's VCT investor magazine Creating Value.
In this edition we profile the latest new investments completed by the Maven VCTs, including specialist on-vehicle advertising platform Drovo, and pre-clinical drug discovery business Laverock Therapeutics.
Also featured is a guest article by Doug Ryan, a senior executive at wealth manager, Mattioli Woods, where he discusses why VCTs are fast becoming a regular feature of wealth and financial planning strategies for many of the company's advisors.
Later in the magazine, we provide an update on the positive progress made by a number of existing VCT portfolio companies which have continued to achieve strategic and operational growth objectives, despite the uncertain macroeconomic backdrop.
Finally we highlight the latest Offers that were recently launched for all four Maven VCTs with applications now being accepted for existing shareholders and new investors.